Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone
Authors
Keywords
Doxorubicin, Mitoxantrone, Cardiotoxicity, Topoisomerase
Journal
ARCHIVES OF TOXICOLOGY
Volume 90, Issue 9, Pages 2063-2076
Publisher
Springer Nature
Online
2016-06-26
DOI
10.1007/s00204-016-1759-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of 3-aminobenzamide on ventricular function in infarct heart assessed by quantitative tissue velocity imaging
- (2016) Man Wang et al. Journal of Cardiovascular Medicine
- Mammalian Base Excision Repair: Functional Partnership between PARP-1 and APE1 in AP-Site Repair
- (2015) Rajendra Prasad et al. PLoS One
- The age factor for mitoxantrone’s cardiotoxicity: Multiple doses render the adult mouse heart more susceptible to injury
- (2015) José Luís Dores-Sousa et al. TOXICOLOGY
- Poly(ADP-ribose): A signaling molecule in different paradigms of cell death
- (2014) Francesca Aredia et al. BIOCHEMICAL PHARMACOLOGY
- Mitochondrial Topoisomerase I (Top1mt) Is a Novel Limiting Factor of Doxorubicin Cardiotoxicity
- (2014) S. Khiati et al. CLINICAL CANCER RESEARCH
- Redox proteomic identification of HNE-bound mitochondrial proteins in cardiac tissues reveals a systemic effect on energy metabolism after doxorubicin treatment
- (2014) Y. Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
- (2014) Yoshihiko Ichikawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Drug-Induced Conformational Population Shifts in Topoisomerase-DNA Ternary Complexes
- (2014) Nan-Lan Huang et al. MOLECULES
- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity
- (2013) Luciana Grazziotin Rossato et al. ARCHIVES OF TOXICOLOGY
- Mitochondrial Cumulative Damage Induced by Mitoxantrone: Late Onset Cardiac Energetic Impairment
- (2013) Luciana Grazziotin Rossato et al. Cardiovascular Toxicology
- Therapeutic Concentrations of Mitoxantrone Elicit Energetic Imbalance in H9c2 Cells as an Earlier Event
- (2013) Luciana Grazziotin Rossato et al. Cardiovascular Toxicology
- The Heart As a Target for Xenobiotic Toxicity: The Cardiac Susceptibility to Oxidative Stress
- (2013) Vera Marisa Costa et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Topoisomerase 2β: A Promising Molecular Target for Primary Prevention of Anthracycline-Induced Cardiotoxicity
- (2013) P Vejpongsa et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The expanding role of PARPs in the establishment and maintenance of heterochromatin
- (2013) Françoise Dantzer et al. FEBS Journal
- Subclinical Myocardial Dysfunction in Multiple Sclerosis Patients Remotely Treated With Mitoxantrone: Evidence of Persistent Diastolic Dysfunction
- (2013) Emer Joyce et al. JOURNAL OF CARDIAC FAILURE
- Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
- (2013) Filipa S. Carvalho et al. MEDICINAL RESEARCH REVIEWS
- Poly(ADP-ribose): PARadigms and PARadoxes
- (2013) Alexander Bürkle et al. MOLECULAR ASPECTS OF MEDICINE
- On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs
- (2013) Chyuan-Chuan Wu et al. NUCLEIC ACIDS RESEARCH
- Drugging Topoisomerases: Lessons and Challenges
- (2012) Yves Pommier ACS Chemical Biology
- Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells
- (2012) Natisha Magan et al. ANTI-CANCER DRUGS
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection
- (2012) Martin Štěrba et al. ANTIOXIDANTS & REDOX SIGNALING
- Mitochondria as a Source of Reactive Oxygen and Nitrogen Species: From Molecular Mechanisms to Human Health
- (2012) Tiago R. Figueira et al. ANTIOXIDANTS & REDOX SIGNALING
- Anthracenedione–methionine conjugates are novel topoisomerase II-targeting anticancer agents with favorable drug resistance profiles
- (2012) Chieh-Hua Lee et al. BIOCHEMICAL PHARMACOLOGY
- Abstract LB-339: Cause of death in cancer survivors
- (2012) Y. Ning et al. CANCER RESEARCH
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
- (2012) V. M. Costa et al. CURRENT MEDICINAL CHEMISTRY
- Application of Fenton, photo-Fenton, solar photo-Fenton, and UV/H2O2 to degradation of the antineoplastic agent mitoxantrone and toxicological evaluation
- (2012) Rodrigo Pereira Cavalcante et al. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- The iron chelator Dp44mT inhibits the proliferation of cancer cells but fails to protect from doxorubicin-induced cardiotoxicity in spontaneously hypertensive rats
- (2011) V. Ashutosh Rao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Unraveling the Biological Roles of Reactive Oxygen Species
- (2011) Michael P. Murphy et al. Cell Metabolism
- Proteomic insights into chronic anthracycline cardiotoxicity
- (2011) Martin Štěrba et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- The Clinically Active PARP Inhibitor AG014699 Ameliorates Cardiotoxicity but Does Not Enhance the Efficacy of Doxorubicin, despite Improving Tumor Perfusion and Radiation Response in Mice
- (2011) M. Ali et al. MOLECULAR CANCER THERAPEUTICS
- Cardiovascular effects of systemic cancer treatment
- (2010) Elżbieta Senkus et al. CANCER TREATMENT REVIEWS
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Poly (ADP-Ribose) Polymerase as a Novel Therapeutic Target in Cancer
- (2010) C. M. Annunziata et al. CLINICAL CANCER RESEARCH
- Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype
- (2010) H Gréen et al. PHARMACOGENOMICS JOURNAL
- Cross-Talk Between Mitochondria and NADPH Oxidase: Effects of Mild Mitochondrial Dysfunction on Angiotensin II-Mediated Increase in Nox Isoform Expression and Activity in Vascular Smooth Muscle Cells
- (2009) João Wosniak et al. ANTIOXIDANTS & REDOX SIGNALING
- Cardiomyocyte death in doxorubicin-induced cardiotoxicity
- (2009) Yi-Wei Zhang et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis
- (2009) S. Cotte et al. BRAIN
- Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells
- (2009) Jenifer Saffi et al. DNA REPAIR
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
- (2009) Milena Sant et al. EUROPEAN JOURNAL OF CANCER
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Oxidative Stress and Mitochondrial DNA Damage in Heart Failure
- (2008) Hiroyuki Tsutsui et al. CIRCULATION JOURNAL
- Cell Death in Heart Failure
- (2008) Kazuhiko Nishida et al. CIRCULATION JOURNAL
- Molecular Recognition Models: A Challenge to Overcome
- (2008) Rafael Caceres et al. CURRENT DRUG TARGETS
- The expanding field of poly(ADP-ribosyl)ation reactions. ‘Protein Modifications: Beyond the Usual Suspects’ Review Series
- (2008) Antoinette Hakmé et al. EMBO REPORTS
- The wanderings of a free radical
- (2008) Barry Halliwell FREE RADICAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started